Zoetis ($ZTS) Insider Trading & Smart Money Activity

Zoetis Inc. · Drug Manufacturers - Specialty & Generic · Latest filing Oct 16, 2026

Zoetis Inc. ($ZTS) has 1 insider trade, 4 congress trades, 10 13F position changes and 1 analyst rating on file. Insiders filed 1 Form 4 transaction in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
4
13F moves on file
10
Analyst ratings on file
1

ZTS insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 1
Q2 2026 0 0 2 / 0 0 / 1
Q3 2026 0 0 1 / 1 0 / 0
Q4 2026 0 0 0 / 0 3 / 5

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ZTS insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Smead Capital Management Added +347.79K sh $110.40M Read
13F Saratoga Research & Investment Management Reduced -3.88K sh $304.74K —
13F Robertson Stephens Wealth Management Added +36.19K sh $3.58M —
13F Howard Capital Management New +82.86K sh $5.79M —
13F Guyasuta Investment Advisors Sold out -4.21K sh Read
13F Community Trust & Investment Sold out -30.91K sh Read
13F First Citizens Bank & Trust Reduced -49.29K sh $837.96K Read
13F Montrusco Bolton Investments Reduced -292.11K sh $57.21M Read
Congress Gilbert Ray Cisneros Jr. Purchase $1,001 - $15,000 -0.5% Read
Congress Gilbert Ray Cisneros Jr. Sale $1,001 - $15,000 -0.9%-4.0% —
Analyst TD Cowen Reiterates to buy PT $104 +6.2%+6.5% Read
Insider Mark Stetter Buy (Grant or award) 318 sh $25.03K -1.1%-2.5% Read
Congress Gilbert Ray Cisneros Jr. Purchase $1,001 - $15,000 -3.1%-3.0% —
Congress Byron Donalds Purchase $1,001 - $15,000 -3.5%-8.7% —
13F Polen Capital Management Reduced -1.34M sh $303.47M +6.1%+5.9% —
13F Cantillon Capital Management Reduced -13.38K sh $86.64M +2.5%-7.6%-40.4% —

1W / 1M / 6M = how ZTS moved from the trade or filing date.

Insider trading in ZTS: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Mark Stetter 1 — Jun 18, 2026

Members of Congress trading ZTS

Institutions moving ZTS (13F)

Analyst ratings on ZTS

DateFirmActionRatingPrice target1W1M6MStory
TD Cowen Reiterates buy $104 +6.2%+6.5% Read

Frequently asked questions

What is the latest insider trade in ZTS?

Mark Stetter filed a buy (grant or award) of 318 sh worth $25.03K on Jun 18, 2026.

Which members of Congress traded ZTS?

4 disclosed trades by Gilbert Ray Cisneros Jr. and Byron Donalds. The latest was on Sep 18, 2026.

Which institutions changed their ZTS positions?

Recent 13F filers moving the stock include Smead Capital Management, Saratoga Research & Investment Management, Robertson Stephens Wealth Management, Howard Capital Management and Guyasuta Investment Advisors.

Other drug manufacturers - specialty & generic stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text